Verition Fund Management LLC lifted its stake in Agilent Technologies, Inc. (NYSE:A) by 28.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,828 shares of the medical research company’s stock after acquiring an additional 1,732 shares during the quarter. Verition Fund Management LLC’s holdings in Agilent Technologies were worth $464,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Balentine LLC boosted its holdings in Agilent Technologies by 2.9% in the second quarter. Balentine LLC now owns 1,794 shares of the medical research company’s stock worth $106,000 after purchasing an additional 50 shares in the last quarter. Sun Life Financial INC boosted its holdings in Agilent Technologies by 26,144.4% in the second quarter. Sun Life Financial INC now owns 2,362 shares of the medical research company’s stock worth $140,000 after purchasing an additional 2,353 shares in the last quarter. Acrospire Investment Management LLC boosted its holdings in Agilent Technologies by 92.3% in the second quarter. Acrospire Investment Management LLC now owns 2,500 shares of the medical research company’s stock worth $148,000 after purchasing an additional 1,200 shares in the last quarter. Parallel Advisors LLC boosted its holdings in Agilent Technologies by 5.3% in the second quarter. Parallel Advisors LLC now owns 2,623 shares of the medical research company’s stock worth $157,000 after purchasing an additional 131 shares in the last quarter. Finally, Trust Co. of Vermont boosted its holdings in Agilent Technologies by 1.8% in the second quarter. Trust Co. of Vermont now owns 2,793 shares of the medical research company’s stock worth $166,000 after purchasing an additional 50 shares in the last quarter.

In related news, CFO Didier Hirsch sold 15,555 shares of the company’s stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $66.00, for a total transaction of $1,026,630.00. Following the completion of the transaction, the chief financial officer now directly owns 178,557 shares in the company, valued at approximately $11,784,762. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Mark Doak sold 12,421 shares of the company’s stock in a transaction that occurred on Friday, August 18th. The shares were sold at an average price of $61.57, for a total transaction of $764,760.97. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 165,720 shares of company stock valued at $10,488,739.

A number of equities research analysts have issued reports on A shares. Zacks Investment Research upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $74.00 price target for the company in a report on Tuesday, October 10th. Jefferies Group LLC restated a “buy” rating and set a $66.00 price target on shares of Agilent Technologies in a report on Wednesday, August 9th. Deutsche Bank AG restated a “buy” rating and set a $66.00 price target on shares of Agilent Technologies in a report on Thursday, June 22nd. Cowen and Company restated a “hold” rating and set a $65.00 price target on shares of Agilent Technologies in a report on Thursday, September 28th. Finally, BidaskClub cut shares of Agilent Technologies from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 12th. Four investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $65.65.

Agilent Technologies, Inc. (NYSE A) opened at 66.88 on Friday. The firm has a market cap of $21.52 billion, a price-to-earnings ratio of 34.49 and a beta of 1.30. Agilent Technologies, Inc. has a 52-week low of $42.92 and a 52-week high of $67.82. The company has a 50-day moving average of $65.65 and a 200 day moving average of $60.29.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Tuesday, August 15th. The medical research company reported $0.59 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.52 by $0.07. The business had revenue of $1.11 billion during the quarter, compared to analysts’ expectations of $1.09 billion. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. The firm’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same period in the prior year, the company earned $0.49 EPS. On average, equities research analysts anticipate that Agilent Technologies, Inc. will post $2.32 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 25th. Investors of record on Tuesday, October 3rd will be given a dividend of $0.132 per share. This represents a $0.53 dividend on an annualized basis and a yield of 0.79%. The ex-dividend date of this dividend is Monday, October 2nd. Agilent Technologies’s dividend payout ratio is 27.32%.

TRADEMARK VIOLATION NOTICE: “Verition Fund Management LLC Boosts Stake in Agilent Technologies, Inc. (A)” was reported by Watch List News and is the property of of Watch List News. If you are accessing this article on another domain, it was stolen and republished in violation of United States & international copyright & trademark legislation. The legal version of this article can be read at https://www.watchlistnews.com/verition-fund-management-llc-boosts-stake-in-agilent-technologies-inc-a/1643572.html.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.